Personalizing Financial Incentives

Exclusion Criteria

• •1. Weight loss of at least 10lbs in the month prior to screening
• •2. Weight \> 380lbs
• •3. Currently enrolled or enrolled in the previous month in a clinical, research, or community program focusing on lifestyle change that could affect weight
• •4. New user of weight loss medication
• •5. Pregnant, lactating or planning on becoming pregnant during the study
• •6. History of bariatric procedure or planning to have bariatric procedure in the study timeframe
• •7. Residing in a nursing home, skilled nursing facility or assisted living facility
• •8. Impaired hearing
• •9. Significant dementia, drug or alcohol abuse, or unstable psychiatric illness (e.g., schizophrenia, psychosis)
• •10. Current treatment for cancer or being treated for cancer (besides basal cell carcinoma or squamous cell) in the last 6 months
• •11. Use of insulin, sulfonylureas, or meglitinides due to increased risk for hypoglycemia
• •12. Diuretic medication doses higher than hydrochlorothiazide or chlorthalidone 25 mg daily, furosemide 40 mg daily, torsemide 20 mg daily, bumetanide 1 mg daily, or any use of metolazone; use of potassium-sparing diuretics is acceptable
• •13. Unstable heart disease in the 6 months prior to screening
• •14. Chronic kidney disease at stage 4 or higher
• •15. Exertional chest pain
• •16. Pain, fainting, or other conditions that prohibit mild/moderate exercise
• •17. History of ascites requiring paracentesis
• •18. Inducing vomiting to prevent weight gain or counteract the effects of eating an average of 1 time per week or more in the past 3 months\*
• •19. Not suitable for study participation due to other reasons at the discretion of the investigators